Cargando…
OvAge: a new methodology to quantify ovarian reserve combining clinical, biochemical and 3D-ultrasonographic parameters
BACKGROUND: In the last decade, both endocrine and ultrasound data have been tested to verify their usefulness for assessing ovarian reserve, but the ideal marker does not yet exist. The purpose of this study was to find, if any, a statistical advanced model able to identify a simple, easy to unders...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392473/ https://www.ncbi.nlm.nih.gov/pubmed/25881987 http://dx.doi.org/10.1186/s13048-015-0149-z |
_version_ | 1782365988023435264 |
---|---|
author | Venturella, Roberta Lico, Daniela Sarica, Alessia Falbo, Maria Pia Gulletta, Elio Morelli, Michele Zupi, Errico Cevenini, Gabriele Cannataro, Mario Zullo, Fulvio |
author_facet | Venturella, Roberta Lico, Daniela Sarica, Alessia Falbo, Maria Pia Gulletta, Elio Morelli, Michele Zupi, Errico Cevenini, Gabriele Cannataro, Mario Zullo, Fulvio |
author_sort | Venturella, Roberta |
collection | PubMed |
description | BACKGROUND: In the last decade, both endocrine and ultrasound data have been tested to verify their usefulness for assessing ovarian reserve, but the ideal marker does not yet exist. The purpose of this study was to find, if any, a statistical advanced model able to identify a simple, easy to understand and intuitive modality for defining ovarian age by combining clinical, biochemical and 3D-ultrasonographic data. METHODS: This is a population-based observational study. From January 2012 to March 2014, we enrolled 652 healthy fertile women, 29 patients with clinical suspect of premature ovarian insufficiency (POI) and 29 patients with Polycystic Ovary syndrome (PCOS) at the Unit of Obstetrics & Gynecology of Magna Graecia University of Catanzaro (Italy). In all women we measured Anti Müllerian Hormone (AMH), Follicle Stimulating Hormone (FSH), Estradiol (E2), 3D Antral Follicle Count (AFC), ovarian volume, Vascular Index (VI) and Flow Index (FI) between days 1 and 4 of menstrual cycle. We applied the Generalized Linear Models (GzLM) for producing an equation combining these data to provide a ready to use information about women ovarian reserve, here called OvAge. To introduce this new variable, expression of ovarian reserve, we assumed that in healthy fertile women ovarian age is identical to chronological age. RESULTS: GzLM applied on the healthy fertile controls dataset produced the following equation OvAge = 48.05 - 3.14*AHM + 0.07*FSH - 0.77*AFC - 0.11*FI + 0.25*VI + 0.1*AMH*AFC + 0.02*FSH*AFC. This model showed a high statistical significance for each marker included in the equation. We applied the final equation on POI and PCOS datasets to test its ability of discovering significant deviation from normality and we obtained a mean of predicted ovarian age significantly different from the mean of chronological age in both groups. CONCLUSIONS: OvAge is one of the first reliable attempt to create a new method able to identify a simple, easy to understand and intuitive modality for defining ovarian reserve by combining clinical, biochemical and 3D-ultrasonographic data. Although design data prove a statistical high accuracy of the model, we are going to plan a clinical validation of model reliability in predicting reproductive prognosis and distance to menopause. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13048-015-0149-z) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4392473 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-43924732015-04-11 OvAge: a new methodology to quantify ovarian reserve combining clinical, biochemical and 3D-ultrasonographic parameters Venturella, Roberta Lico, Daniela Sarica, Alessia Falbo, Maria Pia Gulletta, Elio Morelli, Michele Zupi, Errico Cevenini, Gabriele Cannataro, Mario Zullo, Fulvio J Ovarian Res Research BACKGROUND: In the last decade, both endocrine and ultrasound data have been tested to verify their usefulness for assessing ovarian reserve, but the ideal marker does not yet exist. The purpose of this study was to find, if any, a statistical advanced model able to identify a simple, easy to understand and intuitive modality for defining ovarian age by combining clinical, biochemical and 3D-ultrasonographic data. METHODS: This is a population-based observational study. From January 2012 to March 2014, we enrolled 652 healthy fertile women, 29 patients with clinical suspect of premature ovarian insufficiency (POI) and 29 patients with Polycystic Ovary syndrome (PCOS) at the Unit of Obstetrics & Gynecology of Magna Graecia University of Catanzaro (Italy). In all women we measured Anti Müllerian Hormone (AMH), Follicle Stimulating Hormone (FSH), Estradiol (E2), 3D Antral Follicle Count (AFC), ovarian volume, Vascular Index (VI) and Flow Index (FI) between days 1 and 4 of menstrual cycle. We applied the Generalized Linear Models (GzLM) for producing an equation combining these data to provide a ready to use information about women ovarian reserve, here called OvAge. To introduce this new variable, expression of ovarian reserve, we assumed that in healthy fertile women ovarian age is identical to chronological age. RESULTS: GzLM applied on the healthy fertile controls dataset produced the following equation OvAge = 48.05 - 3.14*AHM + 0.07*FSH - 0.77*AFC - 0.11*FI + 0.25*VI + 0.1*AMH*AFC + 0.02*FSH*AFC. This model showed a high statistical significance for each marker included in the equation. We applied the final equation on POI and PCOS datasets to test its ability of discovering significant deviation from normality and we obtained a mean of predicted ovarian age significantly different from the mean of chronological age in both groups. CONCLUSIONS: OvAge is one of the first reliable attempt to create a new method able to identify a simple, easy to understand and intuitive modality for defining ovarian reserve by combining clinical, biochemical and 3D-ultrasonographic data. Although design data prove a statistical high accuracy of the model, we are going to plan a clinical validation of model reliability in predicting reproductive prognosis and distance to menopause. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13048-015-0149-z) contains supplementary material, which is available to authorized users. BioMed Central 2015-04-08 /pmc/articles/PMC4392473/ /pubmed/25881987 http://dx.doi.org/10.1186/s13048-015-0149-z Text en © Venturella et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Venturella, Roberta Lico, Daniela Sarica, Alessia Falbo, Maria Pia Gulletta, Elio Morelli, Michele Zupi, Errico Cevenini, Gabriele Cannataro, Mario Zullo, Fulvio OvAge: a new methodology to quantify ovarian reserve combining clinical, biochemical and 3D-ultrasonographic parameters |
title | OvAge: a new methodology to quantify ovarian reserve combining clinical, biochemical and 3D-ultrasonographic parameters |
title_full | OvAge: a new methodology to quantify ovarian reserve combining clinical, biochemical and 3D-ultrasonographic parameters |
title_fullStr | OvAge: a new methodology to quantify ovarian reserve combining clinical, biochemical and 3D-ultrasonographic parameters |
title_full_unstemmed | OvAge: a new methodology to quantify ovarian reserve combining clinical, biochemical and 3D-ultrasonographic parameters |
title_short | OvAge: a new methodology to quantify ovarian reserve combining clinical, biochemical and 3D-ultrasonographic parameters |
title_sort | ovage: a new methodology to quantify ovarian reserve combining clinical, biochemical and 3d-ultrasonographic parameters |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392473/ https://www.ncbi.nlm.nih.gov/pubmed/25881987 http://dx.doi.org/10.1186/s13048-015-0149-z |
work_keys_str_mv | AT venturellaroberta ovageanewmethodologytoquantifyovarianreservecombiningclinicalbiochemicaland3dultrasonographicparameters AT licodaniela ovageanewmethodologytoquantifyovarianreservecombiningclinicalbiochemicaland3dultrasonographicparameters AT saricaalessia ovageanewmethodologytoquantifyovarianreservecombiningclinicalbiochemicaland3dultrasonographicparameters AT falbomariapia ovageanewmethodologytoquantifyovarianreservecombiningclinicalbiochemicaland3dultrasonographicparameters AT gullettaelio ovageanewmethodologytoquantifyovarianreservecombiningclinicalbiochemicaland3dultrasonographicparameters AT morellimichele ovageanewmethodologytoquantifyovarianreservecombiningclinicalbiochemicaland3dultrasonographicparameters AT zupierrico ovageanewmethodologytoquantifyovarianreservecombiningclinicalbiochemicaland3dultrasonographicparameters AT ceveninigabriele ovageanewmethodologytoquantifyovarianreservecombiningclinicalbiochemicaland3dultrasonographicparameters AT cannataromario ovageanewmethodologytoquantifyovarianreservecombiningclinicalbiochemicaland3dultrasonographicparameters AT zullofulvio ovageanewmethodologytoquantifyovarianreservecombiningclinicalbiochemicaland3dultrasonographicparameters |